Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 2—February 2017
Research Letter

Emergence of blaNDM-7–Producing Enterobacteriaceae in Gabon, 2016

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Mesmin Moussounda, Seydina M. Diene, Sandra Dos Santos, Alain Goudeau, Patrice FrançoisComments to Author , and Nathalie van der Mee-Marquet
Author affiliations: Hôpital d’Instruction des Armées Omar Bongo Ondimba, Libreville, Gabon (M. Moussounda); Centre Hospitalier Régional Universitaire, Tours, France (M. Moussounda, S. Dos Santos, A. Goudeau, N. van der Mee-Marquet); University of Geneva Hospitals, Geneva, Switzerland (S.M. Diene, P. François)

Cite This Article


Reports of carbapenemase-producing Enterobacteriaceae in Africa remain rare and assess mostly blaOXA-48–producing isolates from Mediterranean countries and South Africa. We identified blaNDM-7–producing Enterobacteriaceae in Gabon in 2016. The isolates contained blaNDM-7 IncX3 plasmids that were unusual and similar to the one described in a colistin-resistant Klebsiella pneumoniae SZ04 isolate from China.

Carbapenems are used as last-line antimicrobial drugs for treating infections caused by multidrug-resistant gram-negative bacilli. Their effectiveness is challenged by the emergence of carbapenemase-producing Enterobacteriaceae (CPE). A new type of β-lactamase, blaNDM, was reported from a patient in Sweden in 2007 (1). Since then, blaNDM CPE have been identified worldwide and described as endemic to the Indian subcontinent and the Balkans (2). In countries to which they are nonendemic, CPE are reported mainly from patients with a history of hospitalization in a CPE-endemic area and, more rarely, in patients without history of travel (3). Reports on CPE in Africa are scarce, likely because monitoring of antimicrobial resistance remains uncommon. blaOXA-48 and blaNDM-1 CPE have been reported from the Maghreb area, Nigeria, Kenya, and South Africa, and single cases of blaNDM-4 and blaNDM-5 Escherichia coli have been reported in Cameroon, Algeria, and Uganda (2,4,5).

In January 2016, we conducted a point-prevalence study in all patients at the military general hospital of Libreville, Gabon. We collected demographic and clinical data and screened patients by rectal swabbing with Amies medium transport swabs (Copan Italia SPA, Brescia, Italy). The swabs were placed in 0.5 mL sterile water; 0.1 mL of the resulting suspension was streaked onto a selective agar plate provided for the identification of bacteria resistant to third-generation cephalosporins (CHROMagar, Paris, France). The plates were incubated for 48 h at 35°C. We used matrix-assisted laser desorption/ionization time-of-flight mass spectrometry technology (Brucker, Bremen, Germany) to confirm each isolate thought to be Enterobacteriaceae.

We performed antimicrobial drug susceptibility testing by the agar disk diffusion method ( Isolates resistant to second- and third-generation cephalosporins were investigated for MIC of ertapenem using Etest (bioMérieux, Marcy-L’Étoile, France) and for carbapenemase production by the CarbaNP test (bioMérieux). For molecular characterization, we performed Sanger sequencing of PCR amplicons of the gene. Purified genomic DNA of the blaNDM-producing isolates was subjected to whole-genome sequencing on a HiSeq system (Illumina, San Diego, CA, USA). Reads were filtered for quality with fastq-mcf (Ea-utils: We used Edena version 2 for genome assembly (3); the genome was annotated by the National Center for Biotechnology Information pipeline. The resistome of the isolates was investigated through the ARG-ANNOT database.

The study was performed in accordance with French and Gabonese recommendations. Ethical approval was obtained at the local level.

We enrolled a total of 138 patients (84 women, 54 men; median age 32 years) in the study. The population had poor health status (a fatal illness likely to occur within the next 5 years for 35.5%; cancer and immunodepression in 5.8% and 22.5%, respectively). Recent hospitalization and antimicrobial drug therapy were reported for 32.5% and 15.9% of patients, respectively. CPE carriage was found in 7 (5.1%) patients and was associated with neonates (p<0.001). The CPE isolates harbored multiple antimicrobial resistance genes (but no mcr-1 or mcr-2) and remained susceptible to tigecycline.

Three isolates harbored blaOXA-48 and 4 a blaNDM-7 determinant (LC154935.1) (Table). blaNDM-7 is an infrequent allele described in Singapore and in patients returning from India (2,6) and was recently identified in patients not connected to a CPE-endemic area (3) and in nosocomial outbreaks (7,8). blaNDM determinants linked to bleMBL are frequently described on conjugative self-transferable IncX3 plasmids. Genome sequence analysis of the 4 Gabon isolates revealed blaNDM-7 and bleMBL carried within a transposon element on a plasmid differing from the blaNDM IncX3 plasmids carried on India isolates but highly similar (20 single-nucleotide polymorphisms) to an IncX3 plasmid in a mcr-1 blaNDM-5–producing Klebsiella pneumoniae strain isolated from a patient from China (9). The 4 patients from whom these isolates were obtained (3 neonates and an 83-year-old woman from the orthopedic unit) had no epidemiologic link with any foreign countries; their acquisition of the blaNDM-7 CPE was unexplained.

Because of the social and economic relationships between China and Gabon, the travels of asymptomatic CPE carriers from China to Gabon can be expected to have facilitated the spread of CPE in Gabon. Several multidrug-resistant clones of K. pneumoniae, including sequence type 307 (10), have been recognized as having emerging epidemic potential worldwide. The genome analysis of the 3 blaNDM-7–producing K. pneumoniae isolates from Gabon revealed clonal isolates (2 and 5 single-nucleotide polymorphisms between them) of sequence type 307. This result suggests an uncontrolled spread in the hospital intensive care unit.

This description of blaNDM-7 in Africa highlights the international dissemination of carbapenemase determinants and the combination of 2 aggravating factors, resulting in an alarming situation: the identification of blaNDM-7 within a transposon element on a conjugative plasmid with a potentially very high level of transmissibility, and the implication of the presence of K. pneumoniae, a pathogen with a high potential to persist and disperse in the hospital environment. Urgent measures are required, including the rational use of antimicrobial drugs, public education on the importance of hygiene, and diligent surveillance to control the spread of these multidrug-resistant organisms in the hospital setting.

Dr. Moussounda is a doctor of pharmacy in the Hôpital d’Instruction des Armées Omar Bongo Ondimba in Libreville, Gabon. He conducted this study in the course of his master’s research in tropical infections at the École Doctorale Régionale in Franceville, Gabon.



  1. Yong  D, Toleman  MA, Giske  CG, Cho  HS, Sundman  K, Lee  K, et al. Characterization of a new metallo-β -lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:504654. DOIPubMedGoogle Scholar
  2. Johnson  AP, Woodford  N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol. 2013;62:499513. DOIPubMedGoogle Scholar
  3. van der Mee-Marquet  N, Diene  S, Chopin  F, Goudeau  A, François  P. Enigmatic occurrence of NDM-7 enzyme in the community. Int J Antimicrob Agents. 2016;47:5057. DOIPubMedGoogle Scholar
  4. Walkty  A, Gilmour  M, Simner  P, Embil  JM, Boyd  D, Mulvey  M, et al. Isolation of multiple carbapenemase-producing gram-negative bacilli from a patient recently hospitalized in Nigeria. Diagn Microbiol Infect Dis. 2015;81:2968. DOIPubMedGoogle Scholar
  5. Okoche  D, Asiimwe  BB, Katabazi  FA, Kato  L, Najjuka  CF. Prevalence and characterization of carbapenem-resistant Enterobacteriaceae isolated from Mulago National Referral Hospital, Uganda. PLoS One. 2015;10:e0135745. DOIPubMedGoogle Scholar
  6. Rahman  M, Shukla  SK, Prasad  KN, Ovejero  CM, Pati  BK, Tripathi  A et al. Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India. Int J Antimicrob Agents. 2014;44:3037. PubMed
  7. Lynch  T, Chen  L, Peirano  G, Gregson  DB, Church  DL, Conly  J et al. Molecular evolution of a Klebsiella pneumoniae ST278 isolate harboring blaNDM-7 and involved in nosocomial transmission. J Infect Dis. 2016;214:798806. PubMed
  8. Chen  L, Peirano  G, Lynch  T, Chavda  KD, Gregson  DB, Church  DL, et al. Molecular characterization by using next-generation sequencing of plasmids containing blaNDM-7 in Enterobacteriaceae from Calgary, Canada. Antimicrob Agents Chemother. 2015;60:125863. DOIPubMedGoogle Scholar
  9. Du  H, Chen  L, Tang  Y-M, Kreiswirth  BN. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis. 2016;16:2878.
  10. Villa  L, Feudi  C, Fortini  D, Iacono  M, Bonura  C, Endimiani  A et al. Complete genome sequence of KPC-3- and CTX-M-15-producing Klebsiella pneumoniae sequence type 307. Genome Announc. 2016;4:e002136.




Cite This Article

DOI: 10.3201/eid2302.161182

Table of Contents – Volume 23, Number 2—February 2017

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Patrice François, Genomic Research Laboratory. Service of Infectious Diseases. University Hospital of Geneva. 1205 Geneva, Switzerland

Send To

10000 character(s) remaining.


Page created: January 18, 2017
Page updated: January 18, 2017
Page reviewed: January 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.